Marshall Gerstein client Onyx Therapeutics prevails on appeal before Federal Circuit in case about Kyprolis® (carfilzomib) product
On March 8, 2021, Law360 reported that Marshall Gerstein client Onyx Therapeutics prevailed on appeal in the case Onyx Therapeutics v. Cipla, Case No. 2020-1875 before the U.S. Court of Appeals for the Federal Circuit. The Federal Circuit affirmed the earlier decision of the U.S. District Court for the District of Delaware, which had ruled in favor of Onyx in May 2020 following a May 2019 bench trial.
Previously, in May 2020, Law360 recognized the Marshall Gerstein team and co-counsel for Onyx as "Legal Lions" as part of its "Weekly Verdict: Legal Lions & Lambs" feature following the district court's trial decision in this case.